Search hospitals > Nevada > Reno
Cancer Care Specialists - Reno
Claim this profileReno, Nevada 89511
Conducts research for Cancer
Conducts research for Colorectal Cancer
Conducts research for Rectal Cancer
Conducts research for Lung Cancer
Conducts research for Brain Tumor
22 reported clinical trials
2 medical researchers
Summary
Cancer Care Specialists - Reno is a medical facility located in Reno, Nevada. This center is recognized for care of Cancer, Colorectal Cancer, Rectal Cancer, Lung Cancer, Brain Tumor and other specialties. Cancer Care Specialists - Reno is involved with conducting 22 clinical trials across 75 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.Area of expertise
1Cancer
Stage I
Stage IV
Stage II
2Colorectal Cancer
Stage II
Stage III
Stage IV
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
158 reported clinical trials
235 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation8 years of reported clinical research
Expert in Cancer
Studies Neuroblastoma
55 reported clinical trials
111 drugs studied
Clinical Trials running at Cancer Care Specialists - Reno
Testicular cancer
Ovarian Carcinoma
Ovarian Tumors
Testicular Carcinoma
Ovarian Choriocarcinoma
Cancer
Germ Cell Tumors
Testicular Choriocarcinoma
Brain Tumor
Primary Malignant Teratoma
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Chemotherapy + Radiation Therapy
for Brain Cancer
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.
Recruiting1 award Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cancer Care Specialists - Reno?
Cancer Care Specialists - Reno is a medical facility located in Reno, Nevada. This center is recognized for care of Cancer, Colorectal Cancer, Rectal Cancer, Lung Cancer, Brain Tumor and other specialties. Cancer Care Specialists - Reno is involved with conducting 22 clinical trials across 75 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.